Navigation Links
Replidyne Announces Restructuring of Operations
Date:8/27/2008

LOUISVILLE, Colo., Aug. 27 /PRNewswire-FirstCall/ -- Replidyne, Inc. (Nasdaq: RDYN) today announced the restructuring of its operations reducing its current employee headcount by approximately 80% to 5 employees in actions that are scheduled to take place during September 2008 and October 2008. As a result of these actions Replidyne will suspend further development activities of REP3123, its investigational agent for the treatment of Clostridium difficile (C. difficile) bacteria and C. difficile Infection (CDI), and novel anti-infective compounds based on its DNA replication inhibition technology. Following completion of the restructuring actions, the Company will limit its activities to completing its review of previously announced strategic alternatives.

"The actions outlined today position us to focus on the strategic alternatives process that we initiated several months ago, as well as preserve our cash resources," stated Kenneth J. Collins, President and Chief Executive Officer of Replidyne. "The process we are conducting involves a number of alternatives including merger or acquisition of the company together with the possible sale of our C. difficile and DNA replication inhibition programs. While the process is ongoing, we are encouraged by our progress to date."

The Company estimates that it will incur $3.1 million of costs related to the restructuring of its operations comprised of $1.6 million for employee severance benefits, $0.8 million for lease payments in excess of expected sub-lease income and $0.7 million of non-cash expense for the write down of impaired fixed assets.

At July 31, 2008 the Company reported $60.7 million in cash and cash equivalents and short term investments and had recorded current l
'/>"/>

SOURCE Replidyne, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
2. ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association
3. DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology
4. Genmab Announces 2008 First Half Year Results
5. QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc.
6. USP announces new tool to help prevent medication mix-ups due to look alike/sound alike drug names
7. Hartwell Medical Announces Release of CombiCarrierII Scoop Backboard to EMS Market
8. iCan Benefit Group, LLC Announces: Major Medical Division Now Offers Avalon Healthcare Products
9. NxStage Announces Presentation of Data at the American Society of Nephrologys Renal Week 2008 Annual Meeting
10. Allscripts Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
11. Corbett Accel Healthcare Group Announces Promotion of Geoff Melick to Executive Vice President, Interactive Marketing & eInnovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2014)... The largest pure occupational medicine company in the ... it will be opening its fifth Georgia center in ... Atlanta-based Nova Medical Centers’ locations. The Augusta facility ... and will be open from 8:30 a.m. to 6 ... philosophy of rapid return-to-work and decreased treatment times for ...
(Date:7/11/2014)... 12, 2014 Recently, DressyQuinceanera.com, a well-known ... Quinceanera Dama dresses to its online category. Furthermore, ... offered at deeply discounted rates, up to 62% off. ... are equally excellent in terms of quality and style. ... Similar discounts are also offered for the company’s other ...
(Date:7/11/2014)... Ticket Down reports that tickets to the Argentina vs. ... Match between Brazil and Netherlands are in high ... July 12th at Estadio Nacional de Brasilia Mane Garrincha Brasila, ... Sunday, July 13th at Estadio Jornalista Mario Filho - Estadio ... World Cup are guaranteed to be authentic and are covered ...
(Date:7/11/2014)... Reducing the number of deer in an area can ... tick-borne infections among people, new research indicates. "Our ... reduce human interactions with deer, infected nymphal ticks and ... White-tailed deer are the primary host for adult ... The study included nearly all the permanent residents of ...
(Date:7/11/2014)... Volunteers from Scientology Churches and Missions ... drug education lectures, forums and conferences, information stands, sports ... the world. , Drug abuse is an international epidemic. ... abuse of alcohol and illicit drugs costs more than ... productivity and healthcare. , In the face of ...
Breaking Medicine News(10 mins):Health News:Nova Medical Centers To Open New Facility in Augusta, Georgia 2Health News:DressyQuinceanera.com: Beautiful Quinceanera Dama Dresses At Low Prices 2Health News:Argentina vs. Germany World Cup Finals Tickets & Brazil vs. Netherlands 3rd Place World Cup Tickets Are in Huge Demand 2Health News:Scientologists Taking Action against Drug Abuse 2Health News:Scientologists Taking Action against Drug Abuse 3
... Bacteria that live in the sub-gingival plaques can increase the ... is published in the current issue of Journal of Periodontology, ... an acute myocardial infarction or heart attack are also the ... plaques were higher than the rest of the participants of ...
... condition of anorexia nervosa and got cured,// often may have ... harmful health condition, the increased body fat does not get ... the body fat often gets deposited in an abnormal way, ... an eating disorder characterized by purposeful weight loss that is ...
... is the commonest cancer effecting men. Benefits of Lycophene- ... and pink grapefruit( most lycopene in processed tomato products ... sometime in preventing the aging process and improve ... now being looked at for preventing and treating cancers ...
... of thyroid cancer may be detectable using a blood ... to a study published by researchers at The ... G. James Cancer Hospital and Richard J. Solove Research ... in the Journal of Clinical Endocrinology & Metabolism. ...
... rinse solution can be of help to decide how far ... mouth rinse of the patients of bone marrow transplant can ... that fight infection in the body. Patients of bone marrow ... of mucositis that may be caused by their treatment procedure. ...
... and linked to the human genetic// makeup. ,Researchers ... Foxp2 gene is found in one of the regions ... autism, and specific language impairment that can cause communication ... engineered mice with Foxp2 gene mutations, results demonstrate that ...
Cached Medicine News:Health News:Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available 2
(Date:7/11/2014)... July 11, 2014  Australian drug delivery company, Phosphagenics ... has raised A$19.3 million via a placement of A$16.3 ... , the U.S., Asia and ... a share purchase plan (SPP) to be offered to ... made in two tranches. "This capital raising ...
(Date:7/11/2014)... , July 11, 2014 According ... Research "Endoscopy Devices Market (Endoscopes, Endoscopic Operative Devices, and ... Trends and Forecast, 2013-2019" the global endoscopy devices market ... is expected to grow at a CAGR of 6.8% ... of USD 36.9 billion in 2019. Browse ...
(Date:7/11/2014)... , July 11, 2014  Veran Medical ... announced today the positive, cost-effective final results ... SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous biopsy ... percutaneous approach to biopsy when a traditional ... and physicians experience positive financial outcomes when ...
Breaking Medicine Technology:Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Veran Medical Publishes Lung Cancer Patient Management Study 2
... BEIJING, May 17, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical ... or the "Company"), an emerging leader in the development, ... medical products, today announced that the Company will present ... be held at the Shanghai Purple Mountain Hotel in ...
... Simbionix USA Corporation, the world,s leading provider ... proud to announce the release two new platform ... Express simulator and the enhanced hardware for ... (Logo: http://photos.prnewswire.com/prnh/20120502/529202-a) ,     (Photo: ...
Cached Medicine Technology:Dehaier Medical to Present at the CFA 2012 Cross-Continental Summit on Investment in Shanghai 2Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events 2
The perfect tool to prepare for in-service or licensing exams, for recertification, or for use as a clinical refresher....
... Sun Med TruFlow™ Oxygen flowmeter with ... lifetime warranty covering calibration and manufacturing defects. ... to meet most needs. Also available with ... auxiliary power take-off and double unit configurations. ...
... Oxygen flowmeter with a Lexan®inner calibrated flow ... and manufacturing defects. A wide range of ... Also available with all popular inlet connections, ... double unit configurations. Our extra large knob ...
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
Medicine Products: